ZED1227

· Dr. Falk Pharma GmbH

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ZED1227, covering 2024-05-14 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease [Phase 2]